Skip to main content
SpringerLink
Log in
Book cover

Resistant Hypertension in Chronic Kidney Disease pp 13–23Cite as

Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: Epidemiological Data

  • Chapter
  • First Online:

Abstract

Chronic kidney disease (CKD) is one of the most common causes of secondary hypertension. The prevalence of hypertension is higher among patients with CKD than in general population, and its frequency increases progressively with the severity of CKD varying in different CKD causes including renal artery stenosis (93%), diabetic nephropathy (87%), and polycystic kidney disease (74%). The pathogenesis of hypertension associated with chronic kidney disease (CKD) is complex and multifactorial and can be associated with diabetic nephropathy, glomerulonephritis, nephropathy in the course of connective tissue disorders, vasculitis, pyelonephritis, and obstructive, analgesic, and reflux nephropathy as well as congenital diseases such as polycystic kidney. It is estimated that only 5–10% of all cases of hypertension is associated with secondary causes. The presence of secondary hypertension is suggested by sudden onset of hypertension, severe increase in blood pressure, and problems to lower blood pressure with the use of drug therapy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.

    Article  Google Scholar 

  2. Tedla FM, Brar A, Browne R, Brown C. Hypertension in chronic kidney disease: navigating the evidence. Int J Hypertens. 2011;2011:132405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Banach M, Aronow WS, Serban C, Sahabkar A, Rysz J, Voroneanu L, Covic A. Lipids, blood pressure and kidney update 2014. Pharmacol Res. 2015;95-96:111–25.

    Article  CAS  PubMed  Google Scholar 

  4. Franczyk-Skóra B, Gluba A, Olszewski R, Banach M, Rysz J. Heart function disturbances in chronic kidney disease: echocardiographic indices. Arch Med Sci. 2014 Dec 22;10(6):1109–16.

    Article  PubMed  PubMed Central  Google Scholar 

  5. U S Renal Data System. USRDS 2010 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2010.

    Google Scholar 

  6. Ridao N, Luño J, García De Vinuesa S, Gómez F, Tejedor A, Valderrábano F. Prevalence of hypertension in renal disease. Nephrol Dial Transplant. 2001;16(1):70–3.

    Article  PubMed  Google Scholar 

  7. Textor SC. Current approaches to renovascular hypertension. Med Clin North Am. 2009;93(3):717.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Banach M, Serban C, Aronow WS, Rysz J, Dragan S, Lerma EV, Apetrii M, Covic A. Lipid, blood pressure and kidney update 2013. Int Urol Nephrol. 2014 May;46(5):947–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Curtis JJ, Luke RG, Dustan HP. Remission of essential hypertension after renal transplantation. N Engl J Med. 1983;309(17):1009–15.

    Article  CAS  PubMed  Google Scholar 

  10. Widgren BR, Herlitz H, Hedner T, et al. Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. Am J Hypertens. 1991;4(7):570–8.

    Article  CAS  PubMed  Google Scholar 

  11. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348(2):101–8.

    Article  PubMed  Google Scholar 

  12. Malyszko J. Chapter: hypertension and the kidneys. In: Myśliwiec M, editor. Great internal medicine. Nephrology, vol. 1. Warszawa, Poland: Medical Tribune; 2015.

    Google Scholar 

  13. Guidelines Committee. 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011–53.

    Article  Google Scholar 

  14. Campese VM, Mitra N, Sandee D. Hypertension in renal parenchymal disease: why is it so resistant to treatment? Kidney Int. 2006;69:967–73.

    Article  CAS  PubMed  Google Scholar 

  15. Malyszko J, Malyszko JS, Rysz J, Mysliwiec M, Tesar V, Levin-Iaina N, Banach M. Renalase, hypertension, and kidney—the discussion continues. Angiology. 2013;64(3):181–7.

    Article  PubMed  Google Scholar 

  16. Gluba A, Mikhailidis DP, Lip GY, Hannam S, Rysz J, Banach M. Metabolic syndrome and renal disease. Int J Cardiol. 2013;164(2):141–50.

    Article  PubMed  Google Scholar 

  17. Tykarski A, Narkiewicz K, Gaciong Z, Januszewicz A, Litwin M, Kostka-Jeziorny K. 2015 guidelines for the Management of Hypertension. Recommendations of the polish Society of Hypertension. Arterial Hypertens. 2015;19(2):53–83.

    Article  Google Scholar 

  18. The Renal Association. CKD stages. Available at: http://www.renal.org/information-resources/the-uk-eckd-guide/ckd-stages#sthash.Ar1Hs9Rh.dpbs.

  19. Malyszko J, Banach M. Pre-CKD- do we need another hero? Curr Vasc Pharmacol. 2014;12(4):642–8.

    Article  CAS  PubMed  Google Scholar 

  20. Banach M, Rysz J. Current problems in hypertension and nephrology. Expert Opin Pharmacother. 2010;11(16):2575–8.

    Article  PubMed  Google Scholar 

  21. Van Buren PN, Toto R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis. 2011;18(1):28–41.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lago RM, Singh PP, Nesto RW. Diabetes and hypertension. Nat Clin Pract Endocrinol Metab. 2007;3:667.

    Article  PubMed  Google Scholar 

  23. Januszewicz A. Arterial hypertension. Outline of pathogenesis, diagnostics and treatment. Kraków: Practical Medicine; 2015.

    Google Scholar 

  24. Rosenthal J, editor. Arterial hypertension: pathogenesis, diagnosis, and therapy. Heidelberg: Springer Science & Business Media; 2012.

    Google Scholar 

  25. Eicken S, Gugger M, Marti HP. Glomerulonephritis and vasculitis as causes of arterial hypertension. Ther Umsch. 2012;69(5):283–94. [Article in German]

    Article  PubMed  Google Scholar 

  26. Olechnowicz-Tietz S, Gluba A, Paradowska A, Banach M, Rysz J. The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol. 2013;45(6):1605–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Rutkowski B. Chronic kidney disease—diagnostics and treatment. Gdańsk: Via Medica; 2012.

    Google Scholar 

  28. Krumme W, Blum U, Schwertfeger E, Flügel P, Höllstin F, Schollmeyer P, Rump LC. Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning. Kidney Int. 1996;50:1288–92.

    Article  CAS  PubMed  Google Scholar 

  29. Vasbinder BGC, Nelemans PJ, Kessels AGH, Kroon AA, De Leeuw PW, van Engelshoven JMA. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med. 2001;135:401–11.

    Article  CAS  PubMed  Google Scholar 

  30. Chapman AB, Stepniakowski K, Rahbari-Oskoui F. Hypertension in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis. 2010;17(2):153–63.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA. Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int. 2001;59:1654–62.

    Article  CAS  PubMed  Google Scholar 

  32. Sans-Atxer L, Torra R, Fernández-Llama P. Hypertension in autosomal-dominant polycystic kidney disease (ADPKD). Clin Kidney J. 2013;6:1–7.

    Article  Google Scholar 

  33. Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, Ritz E. Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int. 1992;42:1259–65.

    Article  CAS  PubMed  Google Scholar 

  34. Fick-Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier RW. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am J Kidney Dis. 2002;39:1127–34.

    Article  PubMed  Google Scholar 

  35. Chapman AB, Johnson AM, Gabow PA, Schrier RW. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1994;5:1349–54.

    CAS  PubMed  Google Scholar 

  36. Henrich WL, Agodoa LE, Barrett B, et al. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis. 1996;27:162–5.

    Article  CAS  PubMed  Google Scholar 

  37. Vadivel N, Trikudanathan S, Singh AK. Analgesic nephropathy. Kidney Int. 2007;72:517–20.

    Article  CAS  PubMed  Google Scholar 

  38. Gluba-Brzózka A, Michalska-Kasiczak M, Franczyk-Skóra B, Nocuń M, Banach M, Rysz J. Markers of increased cardiovascular risk in patients with chronic kidney disease. Lipids Health Dis. 2014;13:135.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Franczyk-Skóra B, Gluba A, Banach M, Rysz J. Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease. Arch Med Sci. 2013;30(9):1019–27.

    Article  Google Scholar 

  40. NKF/DOQI Workgroup. NKF/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney. 2005;45(suppl. 3):S1–53.

    Google Scholar 

  41. Krapf R, Hulter HN. Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin J Am Soc Nephrol. 2009;4(2):470–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Three authors (AG-B, JR, MB) are (partially) supported by the Healthy Ageing Research Centre project (REGPOT-2012-2013-1, 7FP).

Author information

Authors and Affiliations

  1. Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Lodz, Poland

    Beata Franczyk & Jacek Rysz

  2. Department of Nephrology, Hypertension and Family Medicine, WAM Teaching Hospital, Lodz, Poland

    Anna Gluba-Brzózka

  3. Department of Hypertension, Medical University of Lodz, Lodz, Poland

    Maciej Banach

Authors
  1. Beata Franczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Gluba-Brzózka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maciej Banach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jacek Rysz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna Gluba-Brzózka .

Editor information

Editors and Affiliations

  1. Grigore T. Popa University of Medicine, Iaşi, Romania

    Adrian Covic

  2. Department of Medicine, Division of Nephrology, University School of Medicine, Istanbul, Turkey

    Mehmet Kanbay

  3. Section of Nephrology, University of Illinois at Chicago College of Medicine/Advocate Christ Medical Center, Oak Lawn, Illinois, USA

    Edgar V. Lerma

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Franczyk, B., Gluba-Brzózka, A., Banach, M., Rysz, J. (2017). Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: Epidemiological Data. In: Covic, A., Kanbay, M., Lerma, E. (eds) Resistant Hypertension in Chronic Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-56827-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56827-0_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56825-6

  • Online ISBN: 978-3-319-56827-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation